Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)
Health Canada has made changes to the policy on drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement (POL-0004). This policy supports the consistent and transparent application of compliance and enforcement actions under Canada’s GMP and DEL regulatory schemes.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)HTMLEnglish publication HTML
-
Changes to policy on drug good manufacturing practices and DEL enforcement (POL-0004)HTMLFrench publication HTML
Similar records